ADIPOQ and obesity due to melanocortin 4 receptor deficiency: A protective role of HMW adiponectin against the development of obesity, insulin resistance, glucose intolerance, diabetes mellitus, hypertension, metabolic syndrome, atherosclerosis, and cardiovascular disease [33–37] and a negative role of LMW adiponectin on diabetes mellitus and cardiovascular disease have been described [38–41].